MELBOURNE, Australia, April 20, 2017 /PRNewswire/ — IBM (NYSE: IBM ) this week released the results of new research using deep learning and visual analytics technology to advance early detection of diabetic retinopathy (DR) 1 . The results, which classify the degree of severity of the disease in an eye image, exceed other currently published research efforts for severity classification using deep learning and pathology insights. The research found that a new method created by the IBM team achieved an accuracy score of 86 percent in classifying the severity of the disease across the five levels recognized on the […]
Click here to view original web page at www.prnewswire.com
